US Patent 7326679 Anticancer peptide compositions

Patent 7326679 was granted and assigned to TranXenoGen, Inc. on February, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

TranXenoGen, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73266790

Patent Inventor Names

Nathan H. Sloane0

Paul DiTullio0

Alexander Baguisi0

Kathleen M. Hehir0

Date of Patent

February 5, 2008

Patent Application Number

109776290

Date Filed

October 29, 2004

Patent Primary Examiner

‌

Cecilia J. Tsang

Patent abstract

The invention provides compositions and methods for inhibiting angiogenesis associated with tumors and reducing tumor growth.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7326679 Anticancer peptide compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API